Lee HA, Lee S, Yim SV, Kim BH. Bioequivalence of two formulations of pregabalin 150-mg capsules under fasting conditions in healthy male subjects. International Journal of Clinical Pharmacology and Therapeutics. 2017 Feb, 55(2):171-176. doi: 10.5414/CP202698

Chung I, Yoon S, Yi S, Kim B-H, Yim S-V, Jang I-J, Lee H. A bioequivalence study of two levofloxacin tablets in healthy male subjects. Translational and Clinical Pharmacology. 2014;22(2):102.

Chaturvedula A, Sale ME, Lee H. Genetic algorithm guided population pharmacokinetic model development for simvastatin, concurrently or non-concurrently co-administered with amlodipine. Journal of Clinical Pharmacology. 2014;54(2):141-149, Epub 21 SEP 2013 DOI: 10.1002/jcph.176

Lee H, Jang I-J, Yu K-S, Choi J, Oh B-H. A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With Hypertension. Clinical Pharmacology in Drug Development. 2013;2(2):162-72. doi: 10.1002/cpdd.10.

Yim DS, Zhou H, Buckwalter M, Nestorov I, Peck CC, Lee H. Population Pharmacokinetic Analysis and Simulation of the Time Concentration Profile of Etanercept in Pediatric Patients with Juvenile Rheumatoid Arthritis, Journal of Clinical Pharmacology, 2005;45(3):246-256.

Dr. Hyun A Lee is a Senior Manager at Medical & Lifecycle Safety Team in Samsung Bioepis. Dr. Lee was a BK21 Postdoctoral Researcher at the Graduate School of Convergence Science and Technology, Seoul National University. Dr. Lee studied at the Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, and she was also a trainee in clinical pharmacology at the Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital. Dr. Lee graduated from North Carolina State University (NCSU) in the USA with a master’s degree in biomathematics (2010).